Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers

British Journal of Cancer

Volumn 90, Issue 8, 2004, Pages 1531-1537

  Weigelt, B ^a   Verduijn, P ^a   Bosma, A J ^a   Rutgers, E J ^a   Peterse, H L ^a   Van't Veer, L J ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Breast cancer; Metastases; Quantitative real time PCR; Sentinel lymph nodes

Indexed keywords

EOSIN; HEMATOXYLIN; PARAFFIN; RNA; DNA; MESSENGER RNA; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; DISSEMINATED CANCER; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MARKER GENE; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE; STAINING; TUMOR CELL; AXILLA; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE METASTASIS; PATHOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TUMOR MARKERS, BIOLOGICAL;

EID: 2442549498     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601659     Document Type: Article

References (33)

1. Bosma AJ, Weigelt B, Lambrechts AC, Verhagen OJ, Pruntel R, Hart AAM, Rodenhuis S, van't Veer LJ (2002) Detection of circulating breast tumor cells by differential expression of marker genes. Clin Cancer Res 8: 1871-1877
2. Bourez RL, Rutgers EJ (2001) The European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Group: quality control of surgical trials. Surg Oncol Clin N Am 10: 807-819 ix
3. Bourez RL, Rutgers EJ, Van De Velde CJ (2002) Will we need lymph node dissection at all in the future? Clin Breast Cancer 3: 315-322
4. Bieche I, Laurendeau I, Tozlu S, Olivi M, Vidaud D, Lidereau R, Vidaud M (1999) Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res 59: 2759-2765
5. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187
6. Chelly J, Concordet JP, Kaplan JC, Kahn A (1989) Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 86: 2617-2621
7. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Wells CA, European Working Group for Breast Screening Pathology (2003) Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39: 1654-1667
8. De Luca A, Pignata S, Casamassimi A, D'Antonio A, Gridelli C, Rossi A, Cremona F, Parisi V, De Matteis A, Normanno N (2000) Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay. Clin Cancer Res 6: 1439-1444
9. Doting MH, Jansen L, Nieweg OE, Piers DA, Tiebosch AT, Koops HS, Rutgers EJ, Kroon BB, Peterse JL, Olmos RA, de Vries J (2000) Lymphatic mapping with intralesional tracer administration in breast carcinoma patients. Cancer 88: 2546-2552
10. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER (1983) Relation of number of axillary lymph nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551-1557
11. Foster Jr RS (1996) The biologic and clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin N Am 5: 79-104
12. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222: 394-401
13. Giuliano AE, Jones RC, Brennan M, Statman R (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15: 2345-2350
14. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391-401
15. Grube BJ, Giuliano AE (2001) Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 20: 230-237
16. Hellman S (1994) Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol 12: 2229-2234
17. Joensuu H, Pylkkanen L, Toikkanen S (1998) Long-term survival in node-positive breast cancer treated by locoregional therapy alone. Br J Cancer 78: 795-799
18. Kamby C, Rasmussen BB, Kristensen B (1991) Prognostic indicators of metastatic bone disease in human breast cancer. Cancer 68: 2045-2050
19. Kufer P, Zippelius A, Lutterbuse R, Mecklenburg I, Enzmann T, Montag A, Weckermann D, Passlick B, Prang N, Reichardt P, Dugas M, Kollermann MW, Pantel K, Riethmuller G (2002) Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polyraerase chain reaction for diagnosis of micrometastatic disease. Cancer Res 62: 251-261
20. Lambrechts AC, Bosma AJ, Klaver SG, Top B, Perebolte L, Van't Veer LJ, Rodenhuis S (1999) Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells. Breast Cancer Res Treatm 56: 219-231
21. McGuire WL (1987) Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 10: 5-9
22. Miksicek RJ, Myal Y, Watson PH, Walker C, Murphy LC, Leygue E (2002) Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Res 62: 2736-2740
23. Mitas M, Mikhitarian K, Walters C, Baron PL, Elliott BM, Brothers TE, Robison JG, Metcalf JS, Palesch YY, Zhang Z, Gillanders WE, Cole DJ (2001) Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 93: 162-171
24. Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S (1995) Natural history of node-negative breast cancer: a study of 826 patients with long-term follow up. J Clin Oncol 13: 1144-1151
25. Rosen PR, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 7: 355-366
26. Ross MI (2001) Sentinel node dissection in early-stage breast cancer ongoing prospective randomized trials in the USA. Ann Surg Oncol 8: 77S-81S
27. Rutgers EJ, Jansen L, Nieweg OE, de Vries J, Schraffordt Koops H, Kroon BB (1998) Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol 24: 316-319
28. Saimura M, Fukutomi T, Tsuda H, Sato H, Miyamoto K, Akashi-Tanaka S, Nanasawa T (1999) Prognosis of a series of 763 consecutive node-negative invasive breast cancer patients without adjuvant therapy: analysis of clinicopathological prognostic factor. J Surg Oncol 71: 101-105
29. Schroder CP, Ruiters MH, de Jong S, Tiebosch AT, Wesseling J, Veenstra R, de Vries J, Hoekstra HJ, de Leij LF, de Vries EG (2003) Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes. Int J Cancer 106: 611-618
30. Tjan-Heijnen VC, Buit P, de Widt-Evert LM, Ruers TJ, Beex LV (2001) Micrometastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70: 81-88
31. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009
32. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536
33. Zehentner BK, Dillon DC, Jiang Y, Xu J, Bennington A, Molesh DA, Zhang X, Reed SG, Persing D, Houghton RL (2002) Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes. Clin Chem 48: 1225-1231